NASDAQ · Biotechnology

Crispr Therapeutics AG (CRSP)

$39.10 +0.44%
27 Oversold Daily RSI (14) · 19 Nov 2026

Moving averages

SMA 200$52.68-25.78%

Company profile

CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.

SectorHealthcare
IndustryBiotechnology
Market cap$4.44B
P/E ratioNone
EPS$-4.73
Beta1.897
Dividend yield0.00%
52-week high$63.45
52-week low$42.38

ETFs holding CRSP

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for CRSP

An email when CRSP closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 12:30 AM EST